Development, Optimization and Pharmacokinetic Studies of Dasatinib loaded Solid Lipid Nanoparticle and its Therapeutic Efficacy
DOI:
https://doi.org/10.52783/jns.v14.3202Keywords:
SLNPs, Dasatinib, Optmization, Therapeutic efficacy, EvaluationAbstract
This research study emphasises the synthesis and evaluation of Dasatinib-loaded solid lipid nanoparticles (SLNs) to enhance the drug's solubility, bioavailability, and therapeutic efficacy. Dasatinib, a tyrosine kinase inhibitor for Chronic Myeloid Leukaemia (CML), exhibits poor water solubility and restricted oral bioavailability, necessitating the advancement of an enhanced drug delivery method. Solid lipid nanoparticles (SLNs) were chosen as a nanocarrier to enhance medication encapsulation, stability, and controlled release, while minimising systemic adverse effects. The findings of this research suggest that Dasatinib-loaded solid lipid nanoparticles (SLNs) are a viable approach to enhance drug solubility, stability, bioavailability, and therapeutic efficacy in the treatment of chronic myeloid leukaemia (CML).
Downloads
Metrics
References
Alicja P, Alain P, Olivier H, GaelleNoe, Constance T, Stephane O, François G, Michel V, Jerome A. A simple HPLC-UV method for quantification of enzalutamide and its active metabolite N-desmethyl enzalutamide in patients with metastatic castration-resistant prostate cancer. J Chromatogr B 2017; 1058:102-107.
Attama AA. SLN, NLC, LDC: state of the art in drug and active delivery. Recent Pat Drug Deliv Formul. 2011;5(3):178-187. 135. Selvamuthukumar S, Velmurugan R. Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy. Lipids Health Dis. 2012;11(1):159-166.
Baji H. Khan, and Pamu Sandhya. (2022). Formulation and In-vivo Evaluation of Dasatinib-loaded Solid Lipid Nanoparticles. International Journal of Pharmaceutical Sciences and Drug Research, 2022;14(6):824-832. Available online at www.ijpsdronline.com
Beloqui A, Solinis MA, Rodriguez-Gascon A, Almeida AJ, Preat V. Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomedicine. 2016;12(1):143-161.
Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995;12(11):1561-1572.
Deepika V, Naik SS. (2024). Design and Development of Solid Lipid Nanoparticles of Tofacitinib Citrate for the Treatment of Rheumatoid Arthritis: A Quality by Design Approach. International Journal of Drug Delivery Technology. 14(3):1479-1486. https://impactfactor.org/PDF/IJDDT/14/IJDDT,Vol14,Issue3,Article31.pdf
Doktorovova S, Kovacevic AB, Garcia ML, Souto EB. Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2016; 108:235-252
Ekambaram P, Abdul Hasan A. Formulation and Evaluation of Solid Lipid Nanoparticles of Ramipril. J Young Pharm 2011; 3(3):216-220.
Gabriella F. Punu, Yahdiana Harahap, Qonita Kurnia Anjani, Pietradewi Hartrianti, Ryan F. Donnelly, and Delly Ramadon. (2023). Solid Lipid Nanoparticles (SLN): Formulation and Fabrication. Pharmaceutical Sciences and Research (PSR), 10(2), 2023, 55-66. https://scholarhub.ui.ac.id/cgi/viewcontent.cgi?article=1313&context=psr
Gajbhiye, K.R., Salve, R., Narwade, M. (2023). Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics. Mol Cancer 22, 160. https://doi.org/10.1186/s12943-023-01849-0
Garg A, Bhalala K, Tomar DS, Wahajuddin. In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles. Int J Pharm. 2017;516(1-2):120-30.
Gugleva, V., & Andonova, V. (2023). Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms. Pharmaceuticals (Basel, Switzerland), 16(3), 474. https://doi.org/10.3390/ph16030474
Harde H, Das M, Jain S. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin Drug Deliv 2011; 8:1407-1424.
Luo Y, Chen D, Ren L, Zhao X, Qin J. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release. 2006;114(1):53- 59.
Makwana V, Jain R, Patel K, Nivsarkar M, Joshi A. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach. Int J Pharm. 2015;495(1):439- 446.
Mehnert M, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001; 47:165e196.
Mishra, V., Bansal, K. K., Verma, A., Yadav, N., Thakur, S., Sudhakar, K., & Rosenholm, J. M. (2018). Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems. Pharmaceutics, 10(4), 191. https://doi.org/10.3390/pharmaceutics10040191
Moinuddin, Neekhra S, Swarnkar SK, Gupta P, Gupta D, Khunteta A, Kaushik U, Ahmad S. Dasatinib and Hesperidin Loaded Nano Formulation and Preclinical Evaluation for Anticancer Activity. International Journal of Pharmaceutical Quality Assurance. 2023;14(3):579-586. https://impactfactor.org/PDF/IJPQA/14/IJPQA,Vol14,Issue3,Article20.pdf
MuÈller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art. Eur J Pharm Biopharm. 2000;50(1):161-177.
Muhammad S, Mir A, Waheed S, Maqsood-ur-Rehman, Waqar A Shahzeb K. Fabrication, Characterization, and In Vivo Evaluation of Famotidine Loaded Solid Lipid Nanoparticles for Boosting Oral Bioavailability. Journal of Nanomaterials 2017;1: 1-10.
Muller RH, Runge S, Ravelli V, Mehnert W, Thunemann AF, Souto EB. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals. Int J Pharm. 2006;317(1):82-89.
Nguyen, T.-T.-L., & Duong, V.-A. (2022). Solid Lipid Nanoparticles. Encyclopedia, 2(2), 952-973. https://doi.org/10.3390/encyclopedia2020063
Parisa Ghasemiyeh and Soliman Mohammadi-Samani. (2018). Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Research in Pharmaceutical Sciences, 13(4): 288-303. https://pmc.ncbi.nlm.nih.gov/articles/PMC6040163/pdf/RPS-13-288.pdf
Prasad D, Chauhan H. Nanotoxicity of Polymeric and Solid Lipid Nanoparticles. In:. Sutariya VB, Pathak Y, editors. Biointeractions of Nanomaterials. Florida: CRC Press; 2014. pp. 151.
Priyanka SK, Abdul Hasan A. Preparation and Evaluation of Montelukast Sodium Loaded Solid Lipid Nanoparticles. J Young Pharm 2012; 4(3):129-137.
Puglia C, Bonina F. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin Drug Deliv. 2012;9(4):429-241.
Puglia C, Lauro MR, Offerta A, Crasci L, Micicche L, Panico AM, et al. Nanostructured lipid carriers (NLC) as vehicles for topical administration of sesamol: in vitro percutaneous absorption study and evaluation of antioxidant activity. Planta Med. 2017;83(5):398-404.
Puglia C, Offerta A, Tirendi GG, Tarico MS, Curreri S, Bonina F, et al. Design of solid lipid nanoparticles for caffeine topical administration. Drug Deliv. 2016;23(1):36-40.
Russo, E., Spallarossa, A., Tasso, B., Villa, C., & Brullo, C. (2021). Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective. International Journal of Molecular Sciences, 22(12), 6538. https://doi.org/10.3390/ijms22126538
Sangsen Y, Wiwattanawongsa K, Likhitwitayawuid K, Sritularak B, Wiwattanapatapee R. Modification of oral absorption of oxyresveratrol using lipid-based nanoparticles. Colloids Surf B Biointerfaces. 2015; 131:182-190.
Satapathy, M. K., Yen, T. L., Jan, J. S., Tang, R. D., Wang, J. Y., Taliyan, R., & Yang, C. H. (2021). Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB. Pharmaceutics, 13(8), 1183. https://doi.org/10.3390/pharmaceutics13081183
Satapathy, S., & Patro, C. S. (2022). Solid Lipid Nanoparticles for Efficient Oral Delivery of Tyrosine Kinase Inhibitors: A Nano Targeted Cancer Drug Delivery. Advanced pharmaceutical bulletin, 12(2), 298–308. https://doi.org/10.34172/apb.2022.041
Schwarz C, Mehnert W, Lucks JS, Müller RH. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J. Control. Release. 1994;30(1):83-96.
Scioli Montoto S, Muraca G and Ruiz ME (2020). Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects. Front. Mol. Biosci. 7:587997. doi: https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2020.587997/full
Shangguan M, Qi J, Lu Y, Wu W. Comparison of the oral bioavailability of silymarin-loaded lipid nanoparticles with their artificial lipolysate counterparts: implications on the contribution of integral structure. Int J Pharm. 2015;489(1-2):195- 202.
Shidhaye SS, Vaidya R, Sutar S, Patwardhan A, Kadam VJ. Solid lipid nanoparticles and nanostructured lipid carriers-innovative generations of solid lipid carriers. Curr Drug Deliv. 2008;5(4):324-231.
Shyam S Kumar, G. Gopalakrishnan, N. L. Gowrishankar. Design, Optimization and in vitro Characterization of Dasatinib loaded PLGA Nano carrier for Targeted cancer therapy: A Preliminary Evaluation. Research Journal of Pharmacy and Technology. 2021; 14(4):2095-0. doi: 10.52711/0974-360X.2021.00371. https://rjptonline.org/HTMLPaper.aspx?Journal=Research%20Journal%20of%20Pharmacy%20and%20Technology;PID=2021-14-4-47
Silva A, González-Mira E, García ML, Egea MA, Fonseca J, Silva R, et al. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloids Surf B Biointerfaces. 2011;86(1):158-165.
Sinha, S., Ravi, P.R., Somvanshi, M. (2024). Solid lipid nanoparticles for increased oral bioavailability of acalabrutinib in chronic lymphocytic leukaemia. Discover Nano 19, 218. https://doi.org/10.1186/s11671-024-04157-8
Soukharev RA. Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliv Rev 2007; 59:411e418.
Sun, L., Liu, H., Ye, Y. (2023). Smart nanoparticles for cancer therapy. Sig Transduct Target Ther 8, 418. https://doi.org/10.1038/s41392-023-01642-x
Teeranachaideekul V, Chantaburanan T, Junyaprasert VB. Influence of state and crystallinity of lipid matrix on physicochemical properties and permeation of capsaicin-loaded lipid nanoparticles for topical delivery. J Drug Deliv Sci Technol. 2017; 39:300-307.
Wang X, Chen H, Luo Z, Fu X. Preparation of starch nanoparticles in water in oil microemulsion system and their drug delivery properties. Carbohydr Polym. 2016; 138:192-200.
Xiang QY, Wang MT, Chen F, Gong T, Jian YL, Zhang ZR, et al. Lung-targeting delivery of dexamethasone acetate loaded solid lipid nanoparticles. Arch Pharm Res. 2007;30(4):519-525.
Yasmin Begum M, Prathyusha Reddy G. Formulation and evaluation of dasatinib loaded solid lipid nanoparticles, Int J Pharm Pharm Sci 2018; 10 (12): 14-20
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
